I could be wrong but I think he is pursuing both a
Post# of 72440
http://www.ipharminc.com/press-release/2019/3...is-program
For the Phase 3 program, the Company anticipates international clinical trial enrollment, with participating sites located in the U.S. and in Europe . EMA advice is integral to this plan by helping to ensure that the program meets European standards.